Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME(R) trial - Fitchett, D; Zinman, B; Wanner, C (Eur Heart J, 2016)
et al.